Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

Dow Jones
09/06

DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ advanced 1.09% to $573.38 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.32% to 6,481.50 and Dow Jones Industrial Average falling 0.48% to 45,400.86.

This was the stock's second consecutive day of gains.

Regeneron Pharmaceuticals Inc. closed 51.02% below its 52-week high of $1,170.58, which the company achieved on September 13th.

The stock underperformed when compared to some of its competitors Friday, as Amgen Inc. $(AMGN)$ rose 1.26% to $283.64, Moderna Inc. (MRNA) rose 3.54% to $25.14, and Gilead Sciences Inc. (GILD) rose 2.02% to $115.05.

Trading volume (944,416) remained 26,920 below its 50-day average volume of 971,336.

Data source: Dow Jones Market Data, FactSet. Data compiled September 5, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

September 05, 2025 16:46 ET (20:46 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10